Reshma Mahtani, DO

Videos

Optimizing Treatment for Patients With High-Risk HER2-Positive Breast Cancer

02/21/2024

In this video, our experts explore therapy options for patients with high-risk HER2-positive breast cancer, sharing their views on anthracycline-based therapies, neratinib, and immunotherapy for these patients, and discussing data from the...

In this video, our experts...

02/21/2024

Oncology

Videos

Pertuzumab Plus Trastuzumab for Early-Stage HER2-Positive Breast Cancer

02/22/2024

Reshma Mahtani , DO;

Terry Mamounas , MD;

Jane Meisel , MD;

In this video, a panel of experts highlight 8-year updated results from the APHINITY trial and reflect on the progress that has been made in the setting of HER2-positive breast cancer.

In this video, a panel of...

02/22/2024

Oncology

Videos

Managing Patients With Stage 1 HER2-Positive Breast Cancer

02/21/2024

Reshma Mahtani , DO;

Terry Mamounas , MD;

Jane Meisel , MD;

In this video, a panel of experts discuss the management of patients with stage 1, HER2-positive breast cancer, sharing data from several trials in this space, including the APT, ADEPT, and ATEMPT 2.0 trials.

In this video, a panel of...

02/21/2024

Oncology